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Abstract
Pediatric patients on the waiting list for heart transplantation incur the highest risk of death for any organ transplantation. Berlin Heart EXCOR provides a reliable support as a bridge to heart transplantation or recovery for all
pediatric age groups. We report the ﬁrst successful experience of Berlin Heart EXCOR mechanical circulatory support
and heart transplantation in pediatric patients in Saudi Arabia. The purpose of this report is to highlight the clinical
events and share lessons learned from this endeavor.
Keywords: Heart failure, Pediatric cardiomyopathy, Heart transplant, Mechanical circulatory support, Bridge Berlin
Heart EXCOR

1. Introduction

H

eart failure in pediatric population is a major
cause of morbidity and mortality with a variable prevalence that could reach up to 7/10,000 [1].
The waiting list mortality for pediatric heart transplant remains extremely high reaching up to 17%
and 25% for children and infants respectively [2].
In the current era, the evolution of mechanical
circulatory support as a bridge to transplantation
has signiﬁcantly reduced the heart transplant waitlist mortality compared to previous eras with
equivalent post-transplant survival [3,4].
The BH-EXCOR was implanted for the ﬁrst time
in 1990 in the German Heart Center in Berlin, hence
the name Berlin Heart. Thereafter, the BH-EXCOR
gained more wide-spread use around the world
with longer-term application that reached up to 22
months in children [5e7].
Currently, the BH is the only VAD approved for
pediatric patients. It is an extracorporeal, pulsatile,

pneumatic-driven assist device. It can provide left or
right ventricular support or both and it can be used
as a bridge to recovery or transplantation (Figs. 1
and 2).
This report is aimed to share our experience at
King Abdulaziz Cardiac Center at the Ministry of
National Guard Health Affairs, Riyadh, Saudi Arabia, in performing the ﬁrst successful heart transplantation bridged with BH-EXCOR in pediatric
patients in Saudi Arabia.

2. Case series
We present case series of two siblings (brother
and sister) with familial dilated cardiomyopathy,
presented with advanced heart failure requiring
mechanical support.
2.1. Case 1
A Six-year-old boy (height 129 cm, weight 21 kg
and blood group O positive), who was diagnosed at
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revealed severely diminished left ventricular (LV)
function (ejection fraction of 10%). He had mild
mitral valve regurgitation and mild tricuspid
regurgitation. His clinical condition deteriorated
further with low cardiac output and cardiogenic
shock state (INTERMACS-1). He was Initially
placed on Levetronix PediMag device and was
switched over BH-EXCOR LVAD (pump size 30 ml)
in February 2020. He remained on BH-EXCOR for
16-months until he was successfully transplanted in
June 2021. He was discharged home six weeks after
the heart transplantation in excellent clinical
condition.
2.2. Case 2

Fig. 1. Biventricular support EXCOR system. Illustration of the
Biventricular support with BH-EXCOR. 1: Right atrial cannula (RVADinﬂow), 2: Pulmonary artery cannula (RVAD-outﬂow),3: RVAD blood
pump, 4: RVAD driveline, 5: LVAD driveline, 6: LVAD blood pump, 7:
Line representing the exit sites of the cannula outside the body (Extra
corporeal), 8: LV apex cannula (LVAD-inﬂow), 9: Aortic cannula
(LVAD-outﬂow), Line arrows show the direction of blood ﬂow. Artwork
by: Ms. Sarah A. Alghamdi

the age of 4 years. Despite being on a maximum
medical therapy, he continued to require frequent
admissions for intravenous medication, then he
became inotrope-dependent. His echocardiography

A Nine-year-old girl patient, and the older sister
to Case 1, (height 138 cm, weight 32 kg, and blood
group O positive) who was on maximum medical
therapy. At the end of December 2020, she presented to the ER with progressive hypotension and
renal impairment (INTERMACS-2). Despite being
on maximal medical therapy, and inotropic support,
her condition kept deteriorating. Her echocardiography showed severely diminished LV function
(ejection fraction of 5%) and severe mitral valve
regurgitation. The right ventricular function was
moderately diminished with moderate tricuspid
valve regurgitation. In December 2020, BH-EXCOR
LVAD (pump size 30 ml) implantation was performed. Unlike her brother, the sternum was electively left open and was closed 48 hours after the
implantation. She remained well and was transplanted in March 2021 (4-months on BH-EXCOR).
She was discharged home four weeks after heart
transplantation in excellent clinical condition.

3. Discussion

Fig. 2. IKUS driving unit. Image source: Berlin Heart.

Heart transplantation is the gold standard therapy
for end-stage heart failure. There is however, a
shortage of donor organ which leads to waitlist
mortality. The evolution of ventricular assist device
has signiﬁcantly ameliorated the waitlist mortality
and has led to improved candidacy rate for heart
transplantation.
Pediatric patients on BH-EXCOR waiting for heart
transplantation require meticulous and diligent
multidisciplinary care. This care incudes adherence
to the device surveillance and maintenance protocols with regular periodic cannula and pump
checks for thrombin strands, clots, abnormal sounds
or noises at the valve areas and periodic check of the
pump ﬁlling and emptying with the prompt institution of the required adjustment measures.

Anticoagulation is an important aspect to be
tightly controlled. In our patients we utilized the
Edmonton protocol (Warfarin and INR monitoring
with target level between 2.7 and 3.5) modiﬁed by
using dual antiplatelet therapy with ASA and Clopediogril managed by dedicated clinical pharmacist
in collaboration with treating physicians. This
regimen has led to more ﬂexibility in mobilizing the
patients [8].
The infection prevention, early recognition and
treatment are other pillars for success. The cannulas
exit sites are sources of chronic colonization and
potential systemic infections. Our protocol included
strict periodic surveillance of cannulas exit sites
every 48e72 hours and cleaning of the area with
Normal Saline 0.9%, the disinfection with octenidine
solution or gel and the application of an antimicrobial silver dressing around each exit site. Periodic
swabs were collected in order to timely identify any
colonizing microorganism. The dressing change was
performed by critical care nurses speciﬁcally trained
for this procedure. A dedicated team of Infectious
Diseases experts closely monitored both patients
since their admission up until their discharge posttransplant procedures.
Mobility, physiotherapy and optimal nutrition are
cornerstones in the management of patients on BHEXCOR. Dedicated experienced staff are essential to
ensure the maintenance of physical activity, muscle
mass, nutritional support and weight gain. Our patients received regular and systematic physical and
nutritional support including active and passive
exercises and tailored meals. Our patients were
involved in the management of their physical activity and weight by owning a personal log-book for
their activity and weight gain.
The psychological aspects and well-being of these
patients was a major part of their management. It is
obvious that children bound to VAD in the hospital
are subjected to major psychological stress. Our
patients were managed by dedicated pediatric psychologist, psychiatrist, social workers and trained
nursing staff to alleviate their psychological burden.
They were engaged in many programs and activities
including drawing, painting, celebrating events,
competitions and attending on-line schooling.
During the hospital stay on BH-EXCOR, case 1
(the boy) underwent a pump change 12-months
after the implantation due to structural degeneration of the pump valves recognized from abnormal
noise. This pump exchange was done expeditiously
under strict sterile conditions using moderate
sedation. No other major adverse events were
encountered.
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These two cases were not selected, rather, they
came through emergency room. The cases were
accepted and managed after building a strong
infrastructure and trained staff. It should be noted
though, the careful case section -whenever possibleis important to maximize chances of success in a
newly developed program. The success of such a
program, particularly with extended stay on BHEXCOR for 22 months (both siblings) require a
harmonious teamwork with diligent, passionate and
meticulous care that focuses on details while looking at the patient holistically; physical, psychological
and social aspects.

4. Conclusion
We reported the ﬁrst successful experience in
Saudi Arabia, of bridge to transplant in the pediatric
population using BH-EXCOR, in siblings with familial dilated cardiomyopathy.
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